Secretory mechanisms of grepafloxacin and levofloxacin in the human intestinal cell line Caco-2

Journal of Pharmacology and Experimental Therapeutics

Volumn 295, Issue 1, 2000, Pages 360-366

  Yamaguchi, Hiroaki ^a   Yano, Ikuko ^a   Hashimoto, Yukiya ^a   Inui, Ken Ichi ^a  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOHIPPURIC ACID; CIMETIDINE; CYCLOSPORIN A; ENOXACIN; GLYCOPROTEIN P; GREPAFLOXACIN; LEVOFLOXACIN; PROBENECID;

ARTICLE; CELL MEMBRANE TRANSPORT; CELL STRAIN CACO 2; CONCENTRATION RESPONSE; DRUG STRUCTURE; DRUG TRANSPORT; DRUG UPTAKE; HUMAN; HUMAN CELL; MICHAELIS CONSTANT; PRIORITY JOURNAL;

ANTI-INFECTIVE AGENTS; BIOLOGICAL TRANSPORT; CACO-2 CELLS; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUOROQUINOLONES; HUMANS; INTESTINAL MUCOSA; METABOLIC CLEARANCE RATE; OFLOXACIN; PIPERAZINES;

EID: 0033798408     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Multidrug resistance-associated protein: A protein distinct from P-glycoprotein involved in cytotexic drug expulsion
2. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
3. Fluoroquinolone (ciprofloxacin) secretion by human intestinal epithelial (Caco-2) cells
4. Evidence for a passive diffusion mechanism for sparfloxacin uptake at the brush-border membrane of the human intestinal cell-line Caco-2
5. Secretion of sparfloxacin from the human intestinal Caco-2 cell line is altered by P-glycoprotein inhibitors
6. Active intestinal elimination of ciprofloxacin in rats: Modulation by different substrates
7. Pharmacokinetics of grepafloxacin after oral administration of single and repeat doses in healthy young males
8. The clinical pharmacokinetics of levofloxacin
9. Temafloxacin pharmacokinetics in subjects with normal and impaired renal function
10. Active secretion of the fluoroquinolone ciprofloxacin by human intestinal epithelial Caco-2 cell layers
11. Active intestinal secretion of the fluoroquinolone antibacterials ciprofloxacin, norfloxacin and pefloxacin; a common secretory pathway?
12. Molecular physiology of sodium-glucose cotransporters
13. Characterization of the human colon carcinoma cell-line (Caco-2) as a model system for intestinal epithelial permeability
14. The stimulative effect of diffusion potential on enoxacin uptake across rat intestinal brush-border membranes
15. Functional and expression of multidrug resistance-associated protein family in human colon adenocarcinoma cells (Caco-2)
16. Transport properties of the multidrug resistance-associated protein (MRP) in human tumour cells
17. Transport of organic anion in the OK kidney epithelial cell line
18. Functional expression of P-glycoprotein in apical membranes of human intestinal Caco-2 cells: Kinetics of vinblastine secretion and interaction with modulators
19. Transepithelial transport of oral cephalosporins by monolayers of intestinal cell line Caco-2: Specific transport systems in the apical and basolateral membranes
20. The transport mechanisms of organic cations and their zwitterionic derivatives across rat intestinal brush-border membrane. I. Binding characteristics to the bio- and lipid-membranes
21. 1
22. Ofloxacin clinical pharmacokinetics
23. +/peptide cotransporter: Cloning, functional expression, and chromosomal localization
24. +/dipeptide cotransport system in human intestinal cell line Caco-2: Regulation by cell growth
25. 1
26. Interaction with ofloxacin with organic cation transport system in rat renal brush-border membranes
27. Kinetic mechanism for the absorption of ofloxacin
28. 1)
29. +/peptide cotransporter mediating absorption of β-lactam antibiotics in the intestine and kidney
30. Carrier-mediated mechanism for the biliary excretion of the quinolone antibiotic grepafloxacin and its glucuronide in rats
31. Pharmacokinetics disposition of quinolones in human body fluids and tissues
32. Gastrointestinal secretion of ciprofloxacin
33. Comparable pharmacokinetics of ciprofloxacin and temafloxacin in humans: A review
34. Fluoroquinolone antibacterial agents